Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping

2 Jun 2023

Abstract excerpt

Cytogenetic assessment in myelofibrosis is essential for risk stratification and patient management. However, an informative karyotype is unavailable in a significant proportion of patients. Optical genome mapping (OGM) is a promising technique that allows for a high-resolution assessment of chromosomal aberrations (structural variants, copy number variants, and loss of heterozygosity) in a single workflow. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Eosinophilic Disorders and Syndromes
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37297002
DOI: 10.3390/cancers15113039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome MappingPMID 37297002Read ↗

Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML / MDS patientsSemantic proximity Read ↗

Application of Optical Genome Mapping to the Risk Stratification and Treatment Optimization of Hematologic DiseasesSemantic proximity Read ↗

Application of Optical Genome Mapping For Comprehensive Assessment of Chromosomal Structural Variants for Clinical Evaluation of Myelodysplastic SyndromesSemantic proximity Read ↗

High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significanceSemantic proximity Read ↗

Genomic structural variants analysis in leukemia by a novel cytogenetic technique: Optical genome mappingSemantic proximity Read ↗

Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNASemantic proximity Read ↗

Structural Variant Analysis of Complex Karyotype Myelodysplastic Neoplasia Through Optical Genome MappingSemantic proximity Read ↗

Optical Genome Mapping for Cytogenetic Diagnostics in AMLSemantic proximity Read ↗

Optical Genome Mapping improves detection and streamlines analysis of structural variants in myeloid neoplasmsSemantic proximity Read ↗

Optical genome mapping for structural variation analysis in hematologic malignanciesSemantic proximity Read ↗

Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological NeoplasmsSemantic proximity Read ↗

Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.